Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-07-17

Clinical Trial Update: ENDObesity® II Study: TransPyloric Shuttle® System for Weight Loss [NA]

View source ↗

Summary

Clinical trial update for ENDObesity II evaluating the TransPyloric Shuttle system for weight loss has completed, with results posted in 2019.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • TransPyloric Shuttle (TransPyloric Shuttle)

Snippet

Sponsor: BaroNova, Inc. | Conditions: Obesity | NA | Status: COMPLETED | Results posted: 2019-07-17